Pharmafile Logo
Pharmafocus logo
Advanced Search

profits

Showing 8 posts of 8 posts found.

astrazeneca_sign_sky

AstraZeneca Q1 earnings down 12%; maintains FY view

April 29, 2016
Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Q!, earnings, outlook, profits, q, results

UK drugmaker AstraZeneca (LSE: AZN) on Friday reported a 12% drop in first-quarter earnings and said it plans to streamline …

News
Merck image

Revenues down at MSD

February 4, 2016
Sales and Marketing MSD, financial performance, profits, revenue, sales

MSD (Merck, Sharpe and Dohme) reported a mixed bag of financial figures today, as the company announced full-year 2015 revenues …

News

Pfizer revenues down, but above expectations

February 3, 2016
Research and Development, Sales and Marketing Ian Read, Pfizer, financial results, income, profits, revenue, sales

Pfizer’s revenues took a hit from generic competition on former blockbusters, but the world’s new largest drugmaker still managed to …

News
Pfizer sign

Experts predict pharma sector to remain strong in 2016

December 21, 2015
Sales and Marketing marketing, pharma, profits, sales

The year 2016 is set to see continued growth in research and development productivity, with significant new drug launches and …

News
anastrazole

Pharma company vows to plough profits back into R&D

November 30, 2015
Sales and Marketing Australia, R&D, breast cancer, profits, sales, social enterprise

An Australian pharma company has adopted a social enterprise model in order to be able to donate 100% of its …

News
Novartis

Sandoz and pharma division boost Novartis sales

July 21, 2015
Sales and Marketing Alcon, Novartis, Sandoz, financial performance, financial results, income, profits, sales

Sales at Novartis reached $12.7 billion in the second quarter of 2015, while its operating income was $2.3 billion, the …

News
Astrazeneca image

More changes at the top as AstraZeneca profits slip

November 1, 2013
Sales and Marketing AstraZeneca, Crestor, Q3, profits

AstraZeneca’s third quarter revenues and profits fell below analysts’ expectations yesterday, but mitigated the news with the appointment of a …

News
Shanghai image

Patients and profits – time for new priorities

July 29, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, McConaghie, andrew, pharma, profits

Pharmaceutical journalists don’t retire, they just go off patent. Well, I’m not retiring as such, but after ten years as …

Feature

Latest content

Regeneron shares data for multiple myeloma treatment

December 8, 2023

Merck collaborates with Acceleration Consortium for AI experimentation

December 8, 2023

AbbVie to acquire Cerevel Therapeutics for approximately $8.7bn

December 7, 2023

ONK Therapeutics and NAYA Biosciences enter partnership for NK cell therapy development

December 7, 2023

FDA approves Novartis’ Fabhalta for PNH treatment

December 6, 2023